A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine
Journal of Child and Adolescent Psychopharmacology · 2023
DOI: 10.1089/cap.2022.0098 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2023. Verfasst von Melissa P DelBello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Benzodiazepines, Antipsychotic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Melissa P DelBello, Luis Rodrigo Patino Duran, Jeffrey Strawn
Zitieren
APA
DelBello, M. P., Bruns, K. M., Bloom, T., Patino Duran, L. R., Strawn, J., Adler, C. M., & Welge, J. (2023). A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2022.0098
Vancouver
DelBello MP, Bruns KM, Bloom T, Patino Duran LR, Strawn J, Adler CM, et al. A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine. Journal of Child and Adolescent Psychopharmacology. 2023. doi:10.1089/cap.2022.0098
BibTeX
@article{DelBello2023,
author = {DelBello, Melissa P and Bruns, Kaitlyn M and Bloom, Thomas and Patino Duran, Luis Rodrigo and Strawn, Jeffrey and Adler, Caleb M and Welge, Jeffrey},
title = {A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2023},
doi = {10.1089/cap.2022.0098}
}
EUVIMED